retatrutide type 2 diabetes phase 2 results 2024 Archives New Kind of Diabetes Drug

Michael H

The timeline for seeing results from GLP-1 medications varies depending on the specific outcome being measured and the individual patient

Safety Risks of Using Expired Semaglutide or Tirzepatide Expired GLP-1 drugs carry three distinct safety concerns

If chicken sounds too chewy, try yogurt

Clinical trials demonstrate 15-20% body weight reduction with semaglutide and tirzepatide over 68 weeks

FDA Submission Timeline Based on the TRIUMPH-4 success and expected 2026 readouts, analysts predict: Late 2026: Completion of core TRIUMPH trials Q4 2026 or Q1 2027: New Drug Application (NDA) submission to FDA Mid to Late 2027: Potential FDA approval Early 2028: Commercial launch Eli Lilly has not officially confirmed these timelines, but the company has indicated it will submit for regulatory approval once sufficient Phase 3 data is available